Review




Structured Review

Synthego Inc control sgrna
Control Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+non+ntc+sgrna+targeting/pmc13171165-404-18-23
Average 86 stars, based on 1 article reviews
control sgrna - by Bioz Stars, 2026-09
86/100 stars

Images

Related Articles

Negative Control:

Article Title: B cell receptor signaling is a critical regulator of IgE responses
Article Snippet: CRISPR gene targeting was achieved by electroporation of ribonucleoprotein complexes containing Cas9 and single guide RNAs (sgRNAs), adapted from a method published for human B cells.76 Lyophilized modified sgRNAs (Synthego) were designed using Synthego’s sgRNA design tool based on the following criteria in order of importance: 1) cut site within coding region of exon, 2) targeted exon early in coding sequence of protein, 3) cut site early within sequence of exon, 4) high on-target score, 5) target sequence not closely related to off-target sequences. .. Synthego’s negative control sgRNA sequence was used as the negative control sgRNA. sgRNAs were resuspended in TE buffer (Synthego) at 80μM. ..

Article Title: Human LFA-1 governs T cell immune surveillance of the skin
Article Snippet: .. Pools of three single guide RNAs (sgRNAs) targeting either ITGAL (αL) or ITGB2 (β2) and a scrambled negative control sgRNA were purchased from Synthego. ..

Article Title: Flower dependent trafficking of lamellar bodies facilitates maturation of the epidermal barrier.
Article Snippet: Briefly, for KO of hFWE, 600 ng of a modified sgRNA (Synthego CRISPRevolution sgRNA EZ Kit) targeting exon 1 of hFWE (5’-GCAUGACGUGGUGGUACCGC-3’) was complexed with 3ug Alt-R Cas9 V3 (IDT 1081058) in vitro. .. Where indicated, a scrambled negative control sgRNA (Synthego, Negative Control, Scrambled sgRNA#1, mod-sgRNA) was complexed to Alt-R Cas9 V3. ..

Sequencing:

Article Title: B cell receptor signaling is a critical regulator of IgE responses
Article Snippet: CRISPR gene targeting was achieved by electroporation of ribonucleoprotein complexes containing Cas9 and single guide RNAs (sgRNAs), adapted from a method published for human B cells.76 Lyophilized modified sgRNAs (Synthego) were designed using Synthego’s sgRNA design tool based on the following criteria in order of importance: 1) cut site within coding region of exon, 2) targeted exon early in coding sequence of protein, 3) cut site early within sequence of exon, 4) high on-target score, 5) target sequence not closely related to off-target sequences. .. Synthego’s negative control sgRNA sequence was used as the negative control sgRNA. sgRNAs were resuspended in TE buffer (Synthego) at 80μM. ..

Purification:

Article Title: Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Article Snippet: Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-tumour immunity in solid tumours.. In patients with advanced prostate cancer, immunotherapy treatments have largely failed.. Androgen deprivation therapy is classically administered in these patients to inhibit tumour cell growth, and we postulated that this therapy also affects tumour-associated T cells.

Control:

Article Title: Androgen receptor activity in T cells limits checkpoint blockade efficacy.
Article Snippet: Immune checkpoint blockade has revolutionized the field of oncology, inducing durable anti-tumour immunity in solid tumours.. In patients with advanced prostate cancer, immunotherapy treatments have largely failed.. Androgen deprivation therapy is classically administered in these patients to inhibit tumour cell growth, and we postulated that this therapy also affects tumour-associated T cells.

Article Title: Human IL-10–producing Th1 cells exhibit a molecular signature distinct from Tr1 cells in malaria
Article Snippet: Briefly, 2 μL sgRNA (120 μM) (Synthego) and 2 μL Cas9-NLS (40 μM) (QB3 Macrolab) were mixed and incubated for 15 minutes at 37°C to make a 3:1 ratio Cas9-RNP complex. .. Guides used for each gene were MAF: GAAGUCAUUAACAUAUUCCA; IL10: CAGACAAGGCUUGGCAACCC; PRDM1: multi guides, GUGGUGAAGCUCCCUC, UCCCCGGGAGCAAAACC, GGCAGGGAUGGGCUUGG; and control sgRNA #1 (Synthego). .. Bulk CD4+ T cells were purified from cryopreserved PBMCs with the Human CD4+ T cell isolation kit (STEMCELL technologies).



Similar Products

86
Sangon Biotech sgrna mediated gene deletion nonspecific control sirna
Sgrna Mediated Gene Deletion Nonspecific Control Sirna, supplied by Sangon Biotech, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+negative+sirna/pm41857057-326-3-19
Average 86 stars, based on 1 article reviews
sgrna mediated gene deletion nonspecific control sirna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

96
Addgene inc non targeting nt control sgrna
Non Targeting Nt Control Sgrna, supplied by Addgene inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/lentiCRISPR+v2+(Plasmid+%2352961)/pm41840739-171-12-20
Average 96 stars, based on 1 article reviews
non targeting nt control sgrna - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

86
Synthego Inc control sgrna
Control Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+non+ntc+sgrna+targeting/pmc13171165-404-18-23
Average 86 stars, based on 1 article reviews
control sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

93
Addgene inc pu6 sgrna ef1α puro t2a mcherry vector
Pu6 Sgrna Ef1α Puro T2a Mcherry Vector, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/pU6-sgRNA+EF1Alpha-puro-T2A-BFP%2EControl+(Plasmid+%23128749)/bio_rxiv__64898__2025__12__29__696402-248-23-26
Average 93 stars, based on 1 article reviews
pu6 sgrna ef1α puro t2a mcherry vector - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Addgene inc sgrna control
Sgrna Control, supplied by Addgene inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/pLenti+X2+Neo+DEST+(w18-1)+(Plasmid+%2317390)/pm41397992-269-26-28
Average 93 stars, based on 1 article reviews
sgrna control - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

86
Synthego Inc scramble control sgrnas
Scramble Control Sgrnas, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+scramble/bio_rxiv__2025__11__13__688264-374-16-22
Average 86 stars, based on 1 article reviews
scramble control sgrnas - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc negative control sgrna
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble <t>sgRNA</t> or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected <t>with</t> <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Negative Control Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+non+ntc+sgrna+targeting/bio_rxiv__2025__11__05__684493-241-0-7
Average 86 stars, based on 1 article reviews
negative control sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Obio Technology Corp Ltd non targeting control sgrna
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble <t>sgRNA</t> or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected <t>with</t> <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Non Targeting Control Sgrna, supplied by Obio Technology Corp Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+non+targeting/10__1007_slash_s44466___025___00013___1-200-22-55
Average 86 stars, based on 1 article reviews
non targeting control sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc targeting negative controls sgrna
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble <t>sgRNA</t> or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected <t>with</t> <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Targeting Negative Controls Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/control+non+ntc+sgrna+targeting/pmc12822379-262-0-8
Average 86 stars, based on 1 article reviews
targeting negative controls sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

86
Synthego Inc negative controls sgrna
LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble <t>sgRNA</t> or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected <t>with</t> <t>sgRNAs</t> targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.
Negative Controls Sgrna, supplied by Synthego Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/control+sgrna/controls+negative+sgrna/pm41178490-364-1-8
Average 86 stars, based on 1 article reviews
negative controls sgrna - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

Image Search Results


LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with sgRNAs targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.

Journal: bioRxiv

Article Title: An InDel Genomic Variant within a Bifunctional Super-Enhancer for LINC00636 and CD47 Regulation in Breast Cancer

doi: 10.1101/2025.11.05.684493

Figure Lengend Snippet: LINC00636 RNA expression is regulated by a bifunctional SE. (A) LINC00636 and CD47 RNA expression levels decrease upon BET inhibition in BCCL, and this reduction occurs at a greater extent in the cells where the SE is present. Cells were treated with 1 μM JQ1 or I-BET151 for 6 hours and mRNA levels were analyzed by qPCR. DMSO was used as vehicle control. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (B) CRISPRa of the SE locus increases LINC00636 and CD47 RNA expression levels, and this activation occurs at a greater extent in the cells where the SE is present. dCas9-VP64-expressing cells were transfected with scramble sgRNA or sgRNA targeting the E5 core element within the SE. mRNA levels were analyzed by qPCR 48 hours after transfection. Two-way ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001. (C) LINC00636 overexpression does not affect CD47 RNA expression levels. Left image shows the CRISPRa approach used for LINC00636 overexpression targeting LINC00636 TSS. The plots show LINC00636 and CD47 RNA levels in dCas9-VP64-expressing MCF7 cells transfected with sgRNAs targeting two different sites on LINC00636 TSS. mRNA levels were analyzed by qPCR 48 hours after transfection. ANOVA was performed, *p<0.05, **p<0.01, ***p<0.001.

Article Snippet: Negative Control sgRNA (Scrambled sgRNA#1) was from Synthego. sgRNAs target sequences were as follows: sgRNA SE: AAAATACGGTTACTGTGATT sgRNA#1: TCTAGATCTCCCTTTGGTGC sgRNA#2: CTAGAGCAAAAGCTGCTTGT

Techniques: RNA Expression, Inhibition, Control, Activation Assay, Expressing, Transfection, Over Expression